Results 81 to 90 of about 1,465,354 (287)

Estimation of Antiphospholipid Antibodies, Anticardiolipin Antibodies, Beta-2 Glycoprotein 1 Antibodies in Recurrent Pregnancy Loss - A Case-control Study [PDF]

Journal of Clinical and Diagnostic Research, 2018
Introduction: Recurrent miscarriage is the occurrence of three or more consecutive pregnancy loss before 20 weeks of gestation. Antiphospholipid Antibodies (APAs) are one of the causes responsible for recurrent pregnancy loss.
Nilam Bhasker, Meenakshi Kar, Dharmendra Kumar   +2 more
doaj   +1 more source

Triage and care for women with symptoms or diagnosis of pregnancy loss between 14 + 0 and 21 + 6 weeks' gestation

International Journal of Gynecology &Obstetrics, Volume 172, Issue 1, Page 25-50, January 2026.
Abstract Mid‐trimester pregnancy loss (MTL), defined as a pregnancy loss occurring between 14 + 0 and 21 + 6 weeks of gestation, causes significant physical and emotional distress to women and presents clinical challenges to healthcare professionals. It is acknowledged that in low‐resource settings, this guideline might be applicable to births up to 28 
Caroline E. Fox, Rosinder Kaur, Kugajeevan Vigneswaran, Rachel Small, Jenny Carter, Keelin O'Donoghue, Alexander E. P. Heazell, Anna L. David, Nigel Simpson, Angharad Care, Lisa Starrs, Andrew Shennan, Catalina María Valencia González, Priya Soma‐Pillay, Leah Fitzsimmons, Adam J. Devall, Arri Coomarasamy, Mid‐trimester Pregnancy Loss Guideline Consensus Panel, Owen Arthurs, Ruth Bender‐Atik, Phil Bennett, Kirstien Boelaert, Elizabeth Bonney, Leanna Brace, Naomi Carlisle, Davide Casagrandi, Manju Chandiramani, Carolyn Chiswick, Alexandra Emms, Stella Fielder, James Goadsby, Laura Goodfellow, Jim Gray, Jemma Johns, Emma Kirk, Will Lester, Sophie Mackay, Maria Memtsa, Katie Morris, Sunbal Mukhtar, Naimah Raza, Rita Sarquis, Neil Sebire, Lucy Smith, Lucy Spencer, Amos Tetteh, Natalie Woodhead   +46 more
wiley   +1 more source

Anticuerpos anticardiolipina en pacientes con hipertensión arterial esencial [PDF]

, 2014
Los anticuerpos antifosfolípidos pueden activar el endotelio, modificar su función, alterar la regulación del tono vascular, producir daño renal, y así participar en la patogenia de la hipertensión arterial esencial.Antiphospholipid antibodies can ...
Diumenjo, M. S., Maneschi, E., Testasecca, A., Testasecca, E.   +3 more
core  

Anticardiolipin antibodies and coronary heart disease [PDF]

, 2017
Arterial or venous thrombotic events have been described as complications in patients with positive anticardiolipin antibodies (aCL), affecting various organs including the heart.
BURKART, F., DUCKERT, F., MARBET, G. A., TSAKIRIS, D. A.   +3 more
core  

Never say never

Journal of Hospital Medicine, EarlyView.
Gurpreet Dhaliwal, Jagmeet Dhingra, Tom Fraser, Leal Herlitz, James Pile   +4 more
wiley   +1 more source

Systemic Lupus Erythematosus With Catastrophic APS and Libman–Sacks Endocarditis in a Patient With Autoimmune Hemolytic Anemia: A Case Report

Clinical Case Reports, Volume 13, Issue 12, December 2025.
ABSTRACT Systemic lupus erythematosus (SLE) can lead to antiphospholipid syndrome (APS) and catastrophic APS (CAPS), causing severe thrombotic events. This case of autoimmune hemolytic anemia (AIHA) with stroke and Libman–Sacks endocarditis highlights the need for APS evaluation and shows that prompt anticoagulation and immunosuppressive therapy are ...
Soroush Ehsan, Sirous Afshar, Sahel Bakhtiari, Reza Pourfallah, Shabnam Danaei Mehrabad   +4 more
wiley   +1 more source

Risk Factors for Central and Branch Retinal Vein Occlusion: A Meta-Analysis of Published Clinical Data [PDF]

, 2014
Retinal vein occlusion (RVO) is a major cause of vision loss. Of the two main types of RVO, branch retinal vein occlusion (BRVO) is 4 to 6 times more prevalent than central retinal vein occlusion (CRVO).
Kolář Petr
core   +4 more sources

Atypical Manifestation of Primary Antiphospholipid Syndrome: Conservative Management of Celiac Trunk Thrombosis Case Report and Literature Review

Clinical Case Reports, Volume 13, Issue 12, December 2025.
Atypical manifestation of primary antiphospholipid syndrome: Celiac trunk thrombosis. ABSTRACT Aortic and celiac trunk thrombosis is an exceptional manifestation of antiphospholipid syndrome (APS). A 36‐year‐old woman with triple‐positive APS, prior ischemic strokes, and chronic hypertension discontinued her anticoagulation therapy with acenocoumarin 1
Alejandra Albarrán‐Sánchez, Elsy Estefania Pérez‐Pedraza, Jaime Ramírez‐Rodríguez, José Alberto Flores‐Hernández, Andrés Reyes‐Valdés, Gustavo A. Juarez‐Romo, Sofía Martínez‐Jimenéz, Claudia Ramírez‐Rentería   +7 more
wiley   +1 more source

Autoimmune Thrombocytopenia Treated by Low‐Dose Splenic Irradiation Followed by Splenectomy in a Patient With Systemic Lupus Erythematosus

Clinical Case Reports, Volume 13, Issue 12, December 2025.
ABSTRACT Severe autoimmune thrombocytopenia (ATP) in systemic lupus erythematosus (SLE) patients can be life‐threatening when refractory to standard treatments. Low‐dose splenic irradiation (LDSI) can provide temporary platelet recovery before definitive splenectomy.
Ryosuke Hanaoka
wiley   +1 more source

Beyond the Autoimmune Spectrum, Evaluating Ovarian Health in Systemic Lupus Erythematosus Patients: A Case‐Control Study

Health Science Reports, Volume 8, Issue 12, December 2025.
ABSTRACT Background and Aims Systemic lupus erythematosus (SLE) is a chronic autoimmune disease, and recent findings reveal that fertility and ovarian reserve are reduced even in moderate illness, showing that SLE has a direct impact on ovarian function.
Shaghayegh Moradi Alamdarloo, Hoda Naseri, Zahra Habibagahi, Ameneh Keshavarzi, Atefe Hashemi, Sara Haseli, Sepide Javankiani   +6 more
wiley   +1 more source